Abstract:Porcine circovirus type 3 (PCV3) is an emerging swine pathogen associated with acute porcine dermatitis and nephropathy syndrome (PDNS)-like clinical signs, reproductive failure, and multisystemic inflammation. Current evidence shows that PCV3 is spread worldwide, and its high incidence may pose a threat to the global pig industry. Capsid (Cap) protein is the sole structural protein which plays an important role in inducing protective immunity against PCV3 infection. In this study, monoclonal antibodies (mAbs) against Cap protein of PCV3 were produced by the hybridoma technique. Subsequently, 12 serial overlapping peptides (P1 to P12) spanning the entire region of Cap were synthesized to determine the B cell epitope regions using the mAbs. Results from dot-blot and peptide ELISA identified that P3, P9, and P10 were the major B cell antigenic regions. Fine mapping by shorter N- and C-terminal truncated peptides confirmed that the motifs 57 NKPWH 61 , 140 KHSRYFT 146 , and 161 QSLFFF 166 were linear B cell epitopes, which were highly conserved among different PCV3 strains. Interestingly, we found that the motif 140 KHSRYFT 146 was highly conserved in all reported types of PCVs (i.e., PCV1, PCV2, PCV3, and PCV4), except for the substitution (Y → K → R) of the first residue. This is the first research to identify B cell epitopes of PCV3 Cap, and these findings may lead to a better understanding of the antibody–antigen interaction and provide some guidance for PCV3 vaccine design. Key points • The recombinant Cap protein of PCV3 was expressed and purified in soluble form. • PCV3 Cap-specific mAbs prepared in this study had no cross-reactivity with PCV1/PCV2 Cap. • This is the first report of three conserved linear B cell epitopes on PCV3 Cap. • The minimal residues of the epitopes were 57–61 aa, 140–146 aa, and 161–166 aa.

Preparation and Identification of Monoclonal Antibodies Against Cap Protein of Porcine Circovirus Type 2

Characterization and potential use of truncated PCV2 capsid protein and its polyclonal antibody for diagnosis of PCV2 infections.

Preparation and Identification of Specific Monoclonal Antibody against Porcine Circovirus Type 2

Preparation and Identification of Monoclonal Antibodies Specific for Capsid Protein of Porcine Circovirus Type 2

Preparation and Identification of Two Monoclonal Antibodies Against the Capsid Protein of Porcine Circovirus

Preparation and Characterization of Monoclonal Antibodies Against PCV2-Cap Recombiant Protein

A Novel Linear B Cell Epitope of the Porcine Circovirus Type 3 Capsid Protein Identified by Phage Display Technology

Expression, purification and antibody preparation using different constructs of PCV2 capsid protein.

Fine Mapping Of Antigenic Epitopes On Capsid Proteins Of Porcine Circovirus, And Antigenic Phenotype Of Porcine Circovirus Type 2

A broad spectrum monoclonal antibody against porcine circovirus type 2 for antigen and antibody detection

Fine mapping of linear B cell epitopes on capsid protein of porcine circovirus 3

[Antigenic Analysis of the Recombinant Capsid Protein of Porcine Circovirus Type 2].

Expression and immunogenicity analysis of the capsid proteins of porcine circovirus types 2 to 4

Identification of a Conserved B-Cell Epitope on the Capsid Protein of Porcine Circovirus Type 4

In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal.

Preparation and characterization of monoclonal antibodies against PCV2-ORF2 recombinant protein

Expression and immunogenicity of capsid protein of porcine circovirus type 2 with N-terminal chimeric neutralizing epitopes of foot-and-mouth disease virus

Secretory Expression of Cap Protein of Procine Circovirus 2 and Its Immunogenicity

Preparation and Characterization of Monoclonal Antibodies Against PCV2-ORF2 Fusion Protein

Prokaryotic Expression of Cap Protein of Porcine Circovirus Type 2 Virus and Its Primary Application in ELISA

Construction of polycistronic baculovirus surface display vectors to express the PCV2 Cap(d41) protein and analysis of its immunogenicity in mice and swine